TTK Healthcare board meeting scheduled for May 30, 2026 to approve audited financial results for Q4 and FY ended March 31, 2026.
Board will consider recommending dividend for financial year 2025-26 during the upcoming meeting.
Trading window closure for designated persons remains effective from April 1 to June 1, 2026 per insider trading regulations.
Regulatory disclosure filed under SEBI LODR Regulation 29 for board meeting intimation and compliance updates.